PBPH vs. SPGM
PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) and SPGM (SPDR Portfolio MSCI Global Stock Market ETF) are both exchange-traded funds - PBPH is a Health & Biotech Equities fund tracking the BITA Global Pharma and Biotech Select Index, while SPGM is a Global Equities fund tracking the MSCI AC World IMI. Both are passively managed. At a 0.45 correlation, their price movements are largely independent. PBPH charges 0.13%/yr vs 0.09%/yr for SPGM.
Performance
PBPH vs. SPGM - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBPH achieves a 1.75% return, which is significantly lower than SPGM's 13.52% return.
PBPH
- 1D
- 2.92%
- 1M
- 2.45%
- YTD
- 1.75%
- 6M
- 3.89%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
SPGM
- 1D
- 0.57%
- 1M
- 4.58%
- YTD
- 13.52%
- 6M
- 13.92%
- 1Y
- 32.19%
- 3Y*
- 21.80%
- 5Y*
- 11.60%
- 10Y*
- 12.97%
PBPH vs. SPGM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 1.75% | 0.76% |
SPGM SPDR Portfolio MSCI Global Stock Market ETF | 13.52% | 2.13% |
Correlation
The correlation between PBPH and SPGM is 0.45, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Nov 26, 2025 | 0.45 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBPH vs. SPGM — Risk / Return Rank
PBPH
SPGM
PBPH vs. SPGM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Portfolio Building Block World Pharma and Biotech Index ETF (PBPH) and SPDR Portfolio MSCI Global Stock Market ETF (SPGM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| PBPH | SPGM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 2.51 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.73 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.74 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.29 | 0.66 | -0.37 |
Drawdowns
PBPH vs. SPGM - Drawdown Comparison
The maximum PBPH drawdown since its inception was -11.10%, smaller than the maximum SPGM drawdown of -33.97%. Use the drawdown chart below to compare losses from any high point for PBPH and SPGM.
Loading charts...
Drawdown Indicators
| PBPH | SPGM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.10% | -33.97% | +22.87% |
Max Drawdown (1Y)Largest decline over 1 year | — | -9.50% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -16.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.93% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.97% | — |
Current DrawdownCurrent decline from peak | -6.03% | -0.30% | -5.73% |
Average DrawdownAverage peak-to-trough decline | -4.25% | -4.81% | +0.56% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 2.10% | — |
Volatility
PBPH vs. SPGM - Volatility Comparison
Loading charts...
Volatility by Period
| PBPH | SPGM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 3.87% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 10.36% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 17.20% | 12.88% | +4.32% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 17.20% | 16.03% | +1.17% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.20% | 17.57% | -0.37% |
PBPH vs. SPGM - Expense Ratio Comparison
PBPH has a 0.13% expense ratio, which is higher than SPGM's 0.09% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
PBPH vs. SPGM - Dividend Comparison
PBPH's dividend yield for the trailing twelve months is around 0.09%, less than SPGM's 1.78% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PBPH Portfolio Building Block World Pharma and Biotech Index ETF | 0.09% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
SPGM SPDR Portfolio MSCI Global Stock Market ETF | 1.78% | 1.89% | 1.98% | 2.09% | 2.37% | 1.94% | 1.45% | 2.46% | 1.89% | 2.29% | 1.87% | 3.70% |
Frequently Asked Questions
PBPH and SPGM have a correlation of 0.45, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, SPGM is cheaper at 0.09% per year. The better choice depends on whether you care most about return, fees, risk, or income.
SPGM is cheaper with a 0.09% expense ratio, compared with 0.13% for PBPH.
SPGM has the higher dividend yield at 1.78%, compared with 0.09% for PBPH.
PBPH is categorized as Health & Biotech Equities, while SPGM is Global Equities. PBPH tracks BITA Global Pharma and Biotech Select Index, while SPGM tracks MSCI AC World IMI. They also come from different issuers: Portfolio Building Block and State Street. Their fees differ too: 0.13% for PBPH and 0.09% for SPGM.
Find the right allocation for PBPH and SPGM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer